Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Healthy Volunteers
Disease Category: Healthy Patient Studies
Location: United States, AZ

Clinical Trial Details

Overview

Research Study Summary

The DAYBREAK Study

Purpose
This study is testing an oral investigational study drug in people who have been experiencing a decline in memory function, and/or who have been diagnosed with mild Alzheimer’s disease. The main objective of the study is to see whether this drug can slow the decline in memory and mental functioning that occurs in Alzheimer’s disease.
To Learn more

CW ID: 223041
Date Last Changed: February 8, 2017

Clinical Trial Snapshot

Phase
3
Gender
Both Male and Female
Age
55 to 85 Years
Overall Status
Recruiting
Lead Sponsor
Eli Lilly
Duration
3 Years
Facility Type

Eligibility

To join the study you must:
  • Be between 55 and 85 years old
  • Have experienced a gradual loss of memory over the last 6 months (the study team will assess whether this is due to Alzheimer’s disease), or
  • Have been diagnosed with mild Alzheimer’s disease
  • Have a close friend, relative or partner who would be willing to be your study partner throughout the study

More Info

If you join the study, you and your study partner will be asked to attend around 29 appointments (unless otherwise indicated by study staff).

Contact

Margie Pazzi, RN, BSN, Research Nurse and Site Director
Center for Neurosciences
2450 E. River Road
Tucson, AZ 85712
Phone: 520-320-2147
Fax: 520-320-2149

View Map

Research Center Information:

Center for Neurosciences

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.